PMID: 11905653Mar 22, 2002Paper

Conditionally replicative adenoviral vectors for cancer gene therapy

The Lancet Oncology
J Gómez-Navarro, David T Curiel

Abstract

During the past century, many attempts have been made to exploit the ability of some viruses to infect and destroy cancer cells. Crippled, non-replicative viruses have been used as vectors to transfer genes into tumours. Both strategies have serious limitations. The time is now ripe, however, for full convergence of these two research tracks. On the one hand, the intratumoral propagation of replicative viruses would overcome the low levels of gene transfer achieved by current viral vectors. On the other hand, the versatility provided by vectors encoding foreign genes, which are limited in their uses only by our ingenuity, would overcome the physiological barriers to robust propagation of the viral progeny in the tumour. This empowering synthesis will provide truly new opportunities that might realise the promises of gene transfer for the therapy of cancer.

References

Jun 6, 1970·Lancet·H E Webb, C E Smith
Dec 1, 1974·Cancer·T Asada
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·J F ZhangM W Taylor
Mar 11, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Gómez-NavarroJ T Douglas
Apr 5, 2000·The Journal of Clinical Investigation·C Heise, D H Kirn
Jul 10, 1952·Annals of the New York Academy of Sciences·A E MOORE
Jul 1, 1965·Cancer·W A CASSEL, R E GARRETT

❮ Previous
Next ❯

Citations

Jan 20, 2011·Pharmaceutical Research·Guoqin NiuJeffrey A Hughes
Apr 9, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Oh-Joon KwonChae-Ok Yun
Jul 31, 2013·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Yun-feng ShanRoland Andersson
Feb 27, 2004·Gynecologic Oncology·Nicholas B BerryKenneth P Nephew
Mar 22, 2002·Journal of Virological Methods·Nikita Avvakumov, Joe S Mymryk
Dec 4, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S A LaxF F Liu
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A Hemminki
Oct 18, 2001·Cancer Biotherapy & Radiopharmaceuticals·D J Buchsbaum, D T Curiel
May 3, 2002·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Akseli Hemminki, Ronald D Alvarez
Jul 27, 2005·Oral Oncology·Stelios PateromichelakisMax Partridge
Feb 20, 2004·Current Surgery·Pedro J Ramírez, Selwyn M Vickers
Aug 30, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tamotsu SagawaYoshiro Niitsu
Jan 15, 2011·Cancer Treatment Reviews·M G BourkeG C O'Sullivan
Jan 11, 2003·Cancer Gene Therapy·John Nemunaitis, Jeffrey Edelman
Feb 11, 2004·Endocrine Reviews·Luisa BarzonGiorgio Palù
Apr 11, 2006·Human Reproduction Update·Ayman Al-Hendy, Salama Salama
Jun 17, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ravi SinghKostas Kostarelos
Nov 8, 2003·World Journal of Gastroenterology : WJG·Chao Zhang, Zhan-Kui Liu
Aug 6, 2003·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·John Nemunaitis
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tyler O KirbyDavid T Curiel

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.